newsfilter
← Latest News
Business Wire·

ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set to transform therapeutic development. By combining advanced